These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 6857302

  • 21. Recommended standard theophylline doses are inadequate in chronic obstructive pulmonary disease.
    Savage J, Wiseman IC.
    S Afr Med J; 1987 Apr 18; 71(8):508-9. PubMed ID: 3563816
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Circadian variation in plasma theophylline concentrations during maintenance therapy with a sustained-release preparation in patients with obstructive airways disease.
    Taylor DR, Duffin D, Kinney CD, McDevitt DG.
    Br J Clin Pharmacol; 1984 Jul 18; 18(1):27-30. PubMed ID: 6743488
    [Abstract] [Full Text] [Related]

  • 26. Clinical use of controlled-release theophylline in chronic airways obstruction.
    Dal Negro R, Turco P, Pomari C, Cordaro CI.
    J Int Med Res; 1987 Jul 18; 15(6):391-6. PubMed ID: 3436486
    [Abstract] [Full Text] [Related]

  • 27. [Influence of the combination of theophylline and beta 2 agonists by oral route on pulmonary function of patients with chronic obstructive lung disease].
    Carvalho-Pinto RM, Terra Filho M, Cukier A, Santos SR, Verrastro C, Teixeira LR, Vargas FS.
    Rev Hosp Clin Fac Med Sao Paulo; 1991 Jul 18; 46(4):166-9. PubMed ID: 1843713
    [Abstract] [Full Text] [Related]

  • 28. Treatment of chronic obstructive pulmonary disease with two sustained-release theophylline preparations.
    Giosue S, Bernocchi D, Parola D, Munno R, Mancini P.
    J Int Med Res; 1987 Jul 18; 15(6):352-60. PubMed ID: 3325318
    [Abstract] [Full Text] [Related]

  • 29. Time-dependent inhibition of theophylline elimination by erythromycin stearate.
    Adebayo GI, Adewumi MO, Mabadeje AF.
    Biopharm Drug Dispos; 1986 Jul 18; 7(5):479-85. PubMed ID: 3779037
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Theophylline toxicity due to impaired theophylline degradation.
    Jacobs MH, Senior RM.
    Am Rev Respir Dis; 1974 Sep 18; 110(3):342-5. PubMed ID: 4607286
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Euphylong in patients with chronic obstructive airway diseases].
    Kublik A, von Wichert P.
    Pneumologie; 1991 Nov 18; 45 Suppl 4():858-62. PubMed ID: 1812480
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Dose response relation to oral theophylline in severe chronic obstructive airways disease.
    Chrystyn H, Mulley BA, Peake MD.
    BMJ; 1988 Dec 10; 297(6662):1506-10. PubMed ID: 3147048
    [Abstract] [Full Text] [Related]

  • 37. The disposition of theophylline in blood in chronic obstructive lung disease.
    Ebden P, Banks J, Peel T, Buss DC, Routledge PA, Spragg BP.
    Ther Drug Monit; 1986 Dec 10; 8(4):424-6. PubMed ID: 3824427
    [Abstract] [Full Text] [Related]

  • 38. The use of parenteral aminophylline in patients taking slow release theophylline preparations: an observation of clinical practice.
    Arbab OA, Wiggins J, Ayres JG, Stableforth DE.
    Br J Dis Chest; 1985 Apr 10; 79(2):161-71. PubMed ID: 3986120
    [Abstract] [Full Text] [Related]

  • 39. Pulmonary concentrations of dirithromycin and erythromycin during acute exacerbation of mild chronic obstructive pulmonary disease.
    Matera MG, Tufano MA, Polverino M, Rossi F, Cazzola M.
    Eur Respir J; 1997 Jan 10; 10(1):98-103. PubMed ID: 9032500
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.